TD Securities analyst Tim James downgrades Mullen Group (TSX:MTL) from Buy to Hold.
Reneo Pharmaceuticals Added To Russell 2000 And Russell 3000 Indices
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that